Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2025 Earnings Call Transcript November 5, 2025
Teva Pharmaceutical Industries Limited misses on earnings expectations. Reported EPS is $0.372 EPS, expectations were $0.68.
Operator: Hello, and welcome to the Q3 2025 Teva Pharmaceutical Industries Limited Earnings Conference Call. My name is Alex, and I’ll be coordinating today’s call. [Operator Instructions] I’ll now hand over to Chris Stevo, SVP, Investor Relations. Please go...
